Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Zydus supplies first batch of 30,000 COVID KAVACH ELISA tests to ICMR, free of cost

Posted On: 2020-05-21 14:52:23


The first batch of 30,000 COVID KAVACH ELISA Tests manufactured by Zydus Diagnostics, a unit of Cadila Healthcare Limited, has been supplied to Indian Council of Medical Research (ICMR), free of cost. These test kits have been manufactured in technology transfer with ICMR-NIV of Pune for surveillance purposes.

Robust antibody tests are critical for surveillance and understanding the proportion of population exposed to SARSCOV-2 infection.

ICMR-NIV, Pune has successfully developed an indigenous IgG ELISA test for antibody detection for COVID-19. The test was validated at two sites in Mumbai and has been found to have high sensitivity and specificity. In addition, the test will have the advantage of testing 90 samples together in a single run of 2.5 hours. Moreover, ELISA based testing is easily possible even at district level. After development at ICMR-NIV, Pune, technology has been commercialised by Zydus Cadila for mass scale production. The test kits then manufactured at Zydus Cadila were validated by NIV and were found to have high sensitivity & specificity. The test named as 'COVID KAVACH ELISA' have been manufactured in just four days of receiving all necessary materials from ICMR - NIV, Pune.

Speaking on the development, Chairman, Mr. Pankaj R. Patel, said, "This reaffirms our commitment to do everything that we can to help the nation fight this healthcare challenge. We believe that the need of the hour is to be prepared in every way that we can with the latest diagnostic technologies and that is why we are providing the initial supplies at no costs."

Earlier, the Company had partnered with ICMR to be better equipped against infectious disease outbreaks, and help people, who are at high risk, particularly in distant, remote areas of the country. The Company has been manufacturing and marketing a range of ELISA kits for detection and surveillance of rare and neglected diseases in humans and livestock. Zydus Diagnostics has manufactured kits for Chandipura Virus (ELISA), Kyasanur Forest Disease Virus KFDV (ELISA), Hepatitis E Virus (ELISA), Crimean Congo Haemorrhagic fever (IgM and IgG tests) and Measles (IgM) for human testing and Crimean Congo Haemorrhagic fever (ELISA kits for sheep, goat and cattle) and Japanese Encephalitis (ELISA kits for mosquitoes).

Shares of CADILA HEALTHCARE LTD. was last trading in BSE at Rs.337.55 as compared to the previous close of Rs. 325.9. The total number of shares traded during the day was 132415 in over 2823 trades.

The stock hit an intraday high of Rs. 338.85 and intraday low of 325.2. The net turnover during the day was Rs. 44107511.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Newgen Unveils new AI and ML-based Document Classification Service

Mittal Lifestyle Ltd Posts Excellent Results for Year Ended March 2020

IOL Chemicals & Pharmaceuticals Ltd board to consider Q4, FY20 results on June 12, 2020

Safari Industries India Ltd Q4 FY20 consolidated PAT at Rs. 4.68 crore

Jindal Stainless Limited export orders rebound in May-June period

IndusInd Bank launches India's first mobile app based facility for opening current accounts in a paperless manner

TCS Recognized as a Leader in IDC MarketScape for Business and Industrial IoT Consulting and System Integration Services

Cyient Appoints Meenu Bagla as Vice President and Chief Marketing Officer

Vinati Organics Ltd board to consider Q4, FY20 results, final dividend on June 13, 2020

Maruti Suzuki introduces 'Health and Hygiene' range of Genuine Accessories

DCB Bank announces revised External Benchmark Linked Rate from June 5, 2020

Neogen Chemicals adds another marquee investor to its list of shareholders as promoters divest 11.26 lakh shares

Indiabulls Ventures Ltd allots 2,69,09,089 shares

Dishman Carbogen Amcis Ltd Q4 consolidated PAT at Rs. 71.99 crore

Reliance Industries' rights issue receives overwhelming response with subscription of 1.59 times

IOB updates Moody's rating

Moody's downgrades rating of Powergrid

Oriental Hotels Ltd board recommends final dividend of Rs. 0.20 for FY20

IBM and Persistent Systems to accelerate IBM Cloud Pak Deployment and Core IT Modernization for Enterprises

Duncan Engineering Ltd Q4 loss at Rs. 0.80 crore

De Nora India Ltd Q4 PAT at Rs. 2.20 crore

DISA India Ltd Q4 consolidated loss at Rs. 1.63 crore

DCM Shriram Ltd consolidated Q4 FY2020 PAT at Rs. 207.38 crore

Yash Chemex Ltd posts consolidated PAT of Rs. 1.05 crore in Q4 FY20

MAS Financial Services Ltd reports Rs. 35.67 crore consolidated PAT in Q4 FY20

DCM Shriram Ltd approves investment of Rs. 42.40 crores

DISA India Limited board approves final dividend of Rs. 2.50

Vesuvius India Ltd Q1 CY20 PAT drops to Rs. 18.65 crore

Aurobindo Pharma Ltd Q4 consolidated PAT climbs to Rs. 998.57 crore

Cholamandalam Investment and Finance Company Ltd Q4 consolidated PAT slides to Rs. 42.45 crore

JSPL records a 28% YoY rise in monthly Steel sales volumes with the revival of domestic demand

Moody's downgrade HUDCO's rating

Moody's revise credit rating of GAIL India Ltd

Zensar supports Destination: Home in the US for COVID-19 relief initiatives

Gennex Laboratories Limited receives WHO GMP certificate

EESL and GAIL sign an MoU for Trigeneration projects

CRISIL reaffirms long-term bank facilities rating of TNPL

Sinclairs Hotels Ltd fixes June 18, 2020 as record date for stock split

Religare Enterprises Becomes External Debt-free

Moddys downgrades rating of HPCL

CRISIL reaffirms credit rating of Linc Pen & Plastics Ltd

IEX electricity market trades 6005 MU volume in May'20 marking a 47% YoY increase

Transgene Biotek Ltd to license TrabiORAL to GVK Bio

Steel Strips Wheels Ltd bags export orders for 8,000 wheels

Bharti Infratel Ltd appoints Ms. Pooja Jain as CFO

Moodys downgrades rating of Oil India Ltd

AIL Dixon Technologies Private Limited to start manufacturing of Diagnostic Testing Machines for Molbio

Saregama and Facebook strike global licensing deals

Amara Raja Group announces innovative Performance-linked Annual Remuneration during COVID-19 Crisis

Religare completes Kedaara deal in health insurance arm







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019